Imdur and Gingival pain - a phase IV clinical study of FDA data

Summary:

Gingival pain is reported as a side effect among people who take Imdur (isosorbide mononitrate), especially for people who are male, 60+ old, also take Zometa, and have Bone loss.

The phase IV clinical study analyzes which people have Gingival pain when taking Imdur. It is created by eHealthMe based on reports of 17,119 people who have side effects when taking Imdur from the FDA, and is updated regularly.

What is Imdur?

Imdur has active ingredients of isosorbide mononitrate. It is often used in angina. eHealthMe is studying from 17,367 Imdur users. Check the latest studies of Imdur.

What is Gingival pain?

Gingival pain (gum pain) is found to be associated with 904 drugs and 809 conditions by eHealthMe. Check the latest studies of Gingival pain.

On Jul, 12, 2026

17,119 people reported to have side effects when taking Imdur.
Among them, 13 people (0.08%) have Gingival pain.

Among these 13 people:

What is the gender of people who have Gingival pain when taking Imdur? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Gingival pain when taking Imdur? *

What are other drugs people take besides Imdur? *

What are other side effects people have besides Gingival pain? *

Diarrhea: 13 people, 100.00%
Nausea (feeling of having an urge to vomit): 12 people, 92.31%
Pain: 11 people, 84.62%
Osteonecrosis Of Jaw (death of bone of jaw): 10 people, 76.92%
Fatigue (feeling of tiredness): 10 people, 76.92%
Bone Pain: 8 people, 61.54%
Joint Pain: 8 people, 61.54%
Gastritis (inflammation of stomach): 8 people, 61.54%
Tenderness (pain or discomfort when an affected area is touched): 8 people, 61.54%
Injury: 8 people, 61.54%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 5 people, 38.46%
Bone Loss: 5 people, 38.46%
Neuropathy Peripheral (surface nerve damage): 3 people, 23.08%
Multiple Myeloma (cancer of the plasma cells): 3 people, 23.08%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 3 people, 23.08%
Anaemia (lack of blood): 3 people, 23.08%
Renal Cell Carcinoma (a kidney cancer): 2 people, 15.38%
Breast Cancer Metastatic: 2 people, 15.38%
Type 2 Diabetes: 1 person, 7.69%
Renal Cancer Stage Iv (the tumour has spread to areas beyond gerota's fascia and extends into the adrenal gland on the same side of the body as the tumour, possibly to lymph nodes, but not to other parts of the body): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Imdur and have Gingival pain?

- Check whether Gingival pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Imdur:

Imdur (17,367 reports)

Gingival pain treatments and more:

Gingival pain (9,837 reports)

Browse all side effects of Imdur:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gingival pain:

Gingival pain (904 drugs)

Browse all the conditions that are associated with Gingival pain:

Gingival pain (809 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide mononitrate (the active ingredients of Imdur) and Imdur (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.